Tactogen is a biopharma startup that develops empathogen medicines. The startup company offers drug discovery methods, novel molecules, and pharmaceutical preparations that focus on one goal: enabling safer take-home prescription empathogens. It is headquartered in Palo Alto, California, and was founded in 2020 by Ph.D. neuroscientist Matthew Baggott and deeptech serial entrepreneur Luke Pustejovsky.